Display Format Olympics: Systematic Quantitative Comparison of Phage, Yeast, and Ribosome Display Using Identical Evolutionary Challenges

Reviews (e.g., Zhang 2023; Davydova 2022) describe display platforms but lack cross-platform comparisons. Ståhl et al. (2023) detail affibody cloning for multiple systems but don’t benchmark them. I propose a grand challenge: synthesize identical DNA libraries (e.g., randomized affibody scaffolds) and evolve them in parallel using phage, yeast, and ribosome display against the same difficult target (e.g., a membrane protein). Success metrics include: (1) affinity ceiling, (2) convergence speed, (3) library diversity retention, and (4) functional expression yields. Deep sequencing (Ito et al. 2023) would map evolutionary pathways. This addresses a fundamental gap—no study has quantified which platform excels under specific constraints (e.g., speed vs. stability). The outcome would be a decision tree guiding researchers to optimal platforms, reducing wasted effort and accelerating binder discovery.

References:

1. Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning. Tomoyuki Ito, T. D. Nguyen, Yutaka Saito, Yoichi Kurumida, H. Nakazawa, Saki Kawada, H. Nishi, Koji Tsuda, T. Kameda, M. Umetsu (2023). mAbs.
2. Evolution of phage display libraries for therapeutic antibody discovery. Yang Zhang (2023). mAbs.
3. Cloning of Affibody Libraries for Display Methods.. S. Ståhl, L. Hjelm, Charles Dahlsson Leitao, John Löfblom, H. Lindberg (2023). Cold Spring Harbor Protocols.
4. Protein Engineering: Advances in Phage Display for Basic Science and Medical Research. E. Davydova (2022). Biochemistry (Moscow).